Daily Oncology News
Researchers estimate that from 2016 to 2025, national health expenditures will grow at an annual rate of 5.6 percent yearly.
Researchers estimate that out of the 6.8 million current and former smokers eligible for lung cancer screening in 2015, only a fraction received it.
Twenty-three percent of patients with HNSCC had CVD at the time of their diagnosis.
Second study shows increase in lung cancer screening from 1.3 to 2.1 percent from 2010 to 2015
Drug abuse may cause an unusual short-term memory syndrome
Study found 21 percent of those with late-stage non-small cell lung cancer went without therapy, even though it could boost survival.
The Attention and Interpretation Modification for Fear of Breast Cancer Recurrence (AIM-FBCR) intervention helped reduce health worries for survivors of breast cancer.
Annual counseling could reduce prevalence and prevent many smoking-attributable fatalities.
Oral cannabinoids can ease chronic pain and chemotherapy-related nausea, but researchers cite risks, as well.
Moderate but not vigorous activity proved beneficial for patients with metastatic colorectal cancer.
Industry Supported Education
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Immunotherapy and the Future of Prostate Cancer Treatment
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Women Treated for DCIS Have Slightly Lower Risk for All-Cause Mortality
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Nut Consumption Inversely Associated With Lung Cancer Risk
- E-cigarettes and Replacement Nicotine Therapy Safer Than Tobacco Use
- National Health Care Spending Expected to Grow Five Percent Annually
- Patients With Urologic Cancer Need Psycho-oncologic Support to Manage High Stress
- 1 Year of Adjuvant Trastuzumab Improves Long-Term DFS in Early Breast Cancer
- Lenalidomide Maintenance Appears Efficacious for Relapsed DLBCL
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|